Johnson & Johnson (NYSE:JNJ) Shares Bought by CX Institutional

CX Institutional boosted its holdings in shares of Johnson & Johnson (NYSE:JNJ) by 18.6% in the 4th quarter, Holdings Channel reports. The firm owned 58,313 shares of the company’s stock after buying an additional 9,146 shares during the period. CX Institutional’s holdings in Johnson & Johnson were worth $8,433,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in JNJ. Dark Forest Capital Management LP acquired a new position in shares of Johnson & Johnson in the 2nd quarter valued at $223,000. Northwestern Mutual Wealth Management Co. lifted its stake in Johnson & Johnson by 1.0% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 390,025 shares of the company’s stock valued at $57,005,000 after buying an additional 4,046 shares in the last quarter. Granite FO LLC purchased a new position in shares of Johnson & Johnson in the second quarter worth approximately $377,000. Sunbelt Securities Inc. raised its holdings in shares of Johnson & Johnson by 78.4% during the second quarter. Sunbelt Securities Inc. now owns 56,956 shares of the company’s stock valued at $8,325,000 after acquiring an additional 25,032 shares during the period. Finally, William B. Walkup & Associates Inc. purchased a new stake in shares of Johnson & Johnson in the 2nd quarter valued at approximately $1,801,000. Institutional investors and hedge funds own 69.55% of the company’s stock.

Analyst Upgrades and Downgrades

JNJ has been the subject of a number of research analyst reports. Bank of America reduced their target price on Johnson & Johnson from $160.00 to $159.00 and set a “neutral” rating for the company in a report on Thursday, January 23rd. Wells Fargo & Company decreased their price objective on Johnson & Johnson from $166.00 to $152.00 and set an “equal weight” rating for the company in a research report on Thursday, January 23rd. Wolfe Research initiated coverage on Johnson & Johnson in a report on Friday, November 15th. They issued an “outperform” rating and a $190.00 target price on the stock. Cantor Fitzgerald restated an “overweight” rating and set a $215.00 price target on shares of Johnson & Johnson in a report on Wednesday, October 16th. Finally, Stifel Nicolaus dropped their price objective on shares of Johnson & Johnson from $170.00 to $155.00 and set a “hold” rating on the stock in a research note on Thursday, January 23rd. Nine equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $170.06.

Johnson & Johnson Stock Up 4.1 %

JNJ opened at $152.91 on Tuesday. Johnson & Johnson has a twelve month low of $140.68 and a twelve month high of $168.85. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.79 and a current ratio of 1.03. The business has a 50 day moving average price of $147.85 and a 200 day moving average price of $156.10. The firm has a market cap of $368.15 billion, a P/E ratio of 22.99, a price-to-earnings-growth ratio of 2.45 and a beta of 0.51.

Johnson & Johnson (NYSE:JNJ) last released its earnings results on Wednesday, January 22nd. The company reported $2.04 earnings per share for the quarter, topping analysts’ consensus estimates of $1.99 by $0.05. The firm had revenue of $22.52 billion during the quarter, compared to analyst estimates of $22,438,500 billion. Johnson & Johnson had a net margin of 18.20% and a return on equity of 34.35%. The business’s revenue was up 5.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.29 EPS. Research analysts forecast that Johnson & Johnson will post 10.56 EPS for the current year.

Johnson & Johnson Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 4th. Shareholders of record on Tuesday, February 18th will be given a $1.24 dividend. This represents a $4.96 annualized dividend and a yield of 3.24%. The ex-dividend date is Tuesday, February 18th. Johnson & Johnson’s dividend payout ratio is currently 74.59%.

Insider Transactions at Johnson & Johnson

In related news, Director Mark A. Weinberger bought 1,000 shares of the business’s stock in a transaction that occurred on Thursday, December 12th. The stock was purchased at an average cost of $147.22 per share, for a total transaction of $147,220.00. Following the purchase, the director now directly owns 1,000 shares in the company, valued at $147,220. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.16% of the company’s stock.

Johnson & Johnson Profile

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.